Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells
OBJECTIVES: Hypoxia leads to endothelial cell inflammation, apoptosis, and damage, which plays an important role in the complications associated with ischemic cardiovascular disease. As an oxidoreductase, p66Shc plays an important role in the regulation of reactive oxygen species (ROS) production and apoptosis. Ketamine is widely used in clinics. This study was designed to assess the potential protective effect of ketamine against hypoxia-induced injury in human umbilical vein endothelial cells (HUVECs). Moreover, we explored the potential mechanism by which ketamine protected against hypoxia-induced endothelial injury. METHODS: The protective effects of ketamine against hypoxia-induced injury was assessed using cell viability and adhesion assays, quantitative polymerase chain reaction, and western blotting. RESULTS: Our data showed that hypoxia reduced HUVEC viability, increased the adhesion between HUVECs and monocytes, and upregulated the expression of endothelial adhesion molecules at the protein and mRNA levels. Moreover, hypoxia increased ROS accumulation and upregulated p66Shc expression. Furthermore, hypoxia downregulated sirt1 expression in HUVECs. Alternatively, ketamine was shown to reverse the hypoxia-mediated reduction of cell viability and increase in the adhesion between HUVECs and monocytes, ameliorate hypoxia-induced ROS accumulation, and suppress p66Shc expression. Moreover, EX527, a sirt1 inhibitor, reversed the protective effects of ketamine against the hypoxia-mediated reduction of cell viability and increase in adhesion between HUVECs and monocytes. CONCLUSION: Ketamine reduces hypoxia-induced p66Shc expression and attenuates ROS accumulation via upregulating sirt1 in HUVECs, thus attenuating hypoxia-induced endothelial cell inflammation and apoptosis.
Main Authors: | , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Faculdade de Medicina / USP
2020
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322020000100275 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1807-59322020000100275 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1807-593220200001002752020-09-09Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cellsZhou,XiaohuiLiu,JingYang,SiyiSu,YanguangMeng,ZhipengHu,Yuqin Hypoxia Ketamine p66Shc Sirt1 OBJECTIVES: Hypoxia leads to endothelial cell inflammation, apoptosis, and damage, which plays an important role in the complications associated with ischemic cardiovascular disease. As an oxidoreductase, p66Shc plays an important role in the regulation of reactive oxygen species (ROS) production and apoptosis. Ketamine is widely used in clinics. This study was designed to assess the potential protective effect of ketamine against hypoxia-induced injury in human umbilical vein endothelial cells (HUVECs). Moreover, we explored the potential mechanism by which ketamine protected against hypoxia-induced endothelial injury. METHODS: The protective effects of ketamine against hypoxia-induced injury was assessed using cell viability and adhesion assays, quantitative polymerase chain reaction, and western blotting. RESULTS: Our data showed that hypoxia reduced HUVEC viability, increased the adhesion between HUVECs and monocytes, and upregulated the expression of endothelial adhesion molecules at the protein and mRNA levels. Moreover, hypoxia increased ROS accumulation and upregulated p66Shc expression. Furthermore, hypoxia downregulated sirt1 expression in HUVECs. Alternatively, ketamine was shown to reverse the hypoxia-mediated reduction of cell viability and increase in the adhesion between HUVECs and monocytes, ameliorate hypoxia-induced ROS accumulation, and suppress p66Shc expression. Moreover, EX527, a sirt1 inhibitor, reversed the protective effects of ketamine against the hypoxia-mediated reduction of cell viability and increase in adhesion between HUVECs and monocytes. CONCLUSION: Ketamine reduces hypoxia-induced p66Shc expression and attenuates ROS accumulation via upregulating sirt1 in HUVECs, thus attenuating hypoxia-induced endothelial cell inflammation and apoptosis.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.75 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322020000100275en10.6061/clinics/2020/e1865 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Zhou,Xiaohui Liu,Jing Yang,Siyi Su,Yanguang Meng,Zhipeng Hu,Yuqin |
spellingShingle |
Zhou,Xiaohui Liu,Jing Yang,Siyi Su,Yanguang Meng,Zhipeng Hu,Yuqin Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells |
author_facet |
Zhou,Xiaohui Liu,Jing Yang,Siyi Su,Yanguang Meng,Zhipeng Hu,Yuqin |
author_sort |
Zhou,Xiaohui |
title |
Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells |
title_short |
Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells |
title_full |
Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells |
title_fullStr |
Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells |
title_full_unstemmed |
Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells |
title_sort |
ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells |
description |
OBJECTIVES: Hypoxia leads to endothelial cell inflammation, apoptosis, and damage, which plays an important role in the complications associated with ischemic cardiovascular disease. As an oxidoreductase, p66Shc plays an important role in the regulation of reactive oxygen species (ROS) production and apoptosis. Ketamine is widely used in clinics. This study was designed to assess the potential protective effect of ketamine against hypoxia-induced injury in human umbilical vein endothelial cells (HUVECs). Moreover, we explored the potential mechanism by which ketamine protected against hypoxia-induced endothelial injury. METHODS: The protective effects of ketamine against hypoxia-induced injury was assessed using cell viability and adhesion assays, quantitative polymerase chain reaction, and western blotting. RESULTS: Our data showed that hypoxia reduced HUVEC viability, increased the adhesion between HUVECs and monocytes, and upregulated the expression of endothelial adhesion molecules at the protein and mRNA levels. Moreover, hypoxia increased ROS accumulation and upregulated p66Shc expression. Furthermore, hypoxia downregulated sirt1 expression in HUVECs. Alternatively, ketamine was shown to reverse the hypoxia-mediated reduction of cell viability and increase in the adhesion between HUVECs and monocytes, ameliorate hypoxia-induced ROS accumulation, and suppress p66Shc expression. Moreover, EX527, a sirt1 inhibitor, reversed the protective effects of ketamine against the hypoxia-mediated reduction of cell viability and increase in adhesion between HUVECs and monocytes. CONCLUSION: Ketamine reduces hypoxia-induced p66Shc expression and attenuates ROS accumulation via upregulating sirt1 in HUVECs, thus attenuating hypoxia-induced endothelial cell inflammation and apoptosis. |
publisher |
Faculdade de Medicina / USP |
publishDate |
2020 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322020000100275 |
work_keys_str_mv |
AT zhouxiaohui ketamineameliorateshypoxiainducedendothelialinjuryinhumanumbilicalveinendothelialcells AT liujing ketamineameliorateshypoxiainducedendothelialinjuryinhumanumbilicalveinendothelialcells AT yangsiyi ketamineameliorateshypoxiainducedendothelialinjuryinhumanumbilicalveinendothelialcells AT suyanguang ketamineameliorateshypoxiainducedendothelialinjuryinhumanumbilicalveinendothelialcells AT mengzhipeng ketamineameliorateshypoxiainducedendothelialinjuryinhumanumbilicalveinendothelialcells AT huyuqin ketamineameliorateshypoxiainducedendothelialinjuryinhumanumbilicalveinendothelialcells |
_version_ |
1756432356892213248 |